Effects of impaired renal function on the pharmacokinetics of raltitrexed (Tomudex ZD1694).

This open-label, non-randomized, parallel-group trial investigated the pharmacokinetics of raltitrexed (Tomudex, formerly ZD1694) after a single intravenous dose of 3.0 mg m(-2), comparing eight cancer patients with mild to moderate renal impairment (creatinine clearance 25-65 ml min(-1)) with eight...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Judson, I., Maughan, T., Beale, P., Primrose, J., Hoskin, P., Hanwell, J., Berry, C., Walker, M., Sutcliffe, F.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group|1 1998
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2062997/
https://ncbi.nlm.nih.gov/pubmed/9820178
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars